🇺🇸 Unfractioned heparin in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 23

Most-reported reactions

1. Thrombosis In Device — 5 reports (21.74%)
2. Pulmonary Embolism — 3 reports (13.04%)
3. Thrombocytopenia — 3 reports (13.04%)
4. Catheter Site Discharge — 2 reports (8.7%)
5. Drug Ineffective — 2 reports (8.7%)
6. Petechiae — 2 reports (8.7%)
7. Premature Delivery — 2 reports (8.7%)
8. Retroperitoneal Haemorrhage — 2 reports (8.7%)
9. Anaemia — 1 report (4.35%)
10. Apallic Syndrome — 1 report (4.35%)

Source database →

Frequently asked questions

Is Unfractioned heparin approved in United States?

Unfractioned heparin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Unfractioned heparin in United States?

Universidad de Antioquia is the originator. The local marketing authorisation holder may differ — check the official source linked above.